Funding to support lead candidate targeting FAP and pipeline expansion
News
VarmX secures US approval to begin phase 3 trial of urgent surgery treatment
New trial to test VMX-C001’s effectiveness in restoring coagulation in FXa DOAC patients
Clinical Researcher of the Year – The Americas
Enter the 2025 PharmaTimes Clinical Researcher of the Year – The Americas
First patient dosed in trial for novel dry AMD treatment PST-611
PulseSight begins phase 1 safety study of gene therapy for geographic atrophy
Eladynos recommended for osteoporosis treatment in Scottish NHS
SMC approval provides option for postmenopausal women at risk of fractures
First German haemophilia B patient receives gene therapy HEMGENIX
CSL Behring marks new era in treatment with milestone reimbursement model
Neumifil shows promise in treating influenza with positive phase 2 data
Pneumagen’s intranasal antiviral demonstrates reduced infection
Moderna flu vaccine shows superior results in phase 3 study
Data shows mRNA-1010 could better protect adults aged 50 and above
UCB reports success in phase 3 study of fenfluramine for CDD
Positive trial results offer hope for those with ultra-rare epileptic disorder
Cidara and hVIVO report positive results in flu prevention study
New data show strong efficacy of CD388 in phase 2b trial
NHS ConfedExpo 2025: a platform for change in UK health and care
This year’s event took place on 11 to 12 June at Manchester Central
Excellence in Healthcare Partnerships Awards launched by PMGroup and Visions4Health
The programme was unveiled at this year’s NHS ConfedExpo in Manchester
2025 PharmaTimes Clinical Researcher of the Year
Enter this year’s famous competition
NHS rolls out new initiative to identify pancreatic cancer earlier
The pilot will see GP practices look at patient records to identify those most at risk
eXmoor and Signadori Bio enter cell therapy partnership
Signadori is advancing a platform designed to overcome the challenges of treating solid cancers
